Ignite Creation Date:
2024-05-06 @ 10:18 AM
Last Modification Date:
2024-10-26 @ 12:28 PM
Study NCT ID:
NCT03222843
Status:
COMPLETED
Last Update Posted:
2022-08-03
First Post:
2017-07-18
Brief Title:
Multicentre Randomised Phase III Study of the Efficacy and Safety of Hetrombopag Olamine in Idiopathic Thrombocytopenic Purpura ITP Patient
Sponsor:
Jiangsu HengRui Medicine Co Ltd
Organization:
Jiangsu HengRui Medicine Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-30
Start Date Type:
ACTUAL
Primary Completion Date:
2019-11-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-01-07
Completion Date Type:
ACTUAL
First Submit Date:
2017-07-18
First Submit QC Date:
July 18 2017
Study First Post Date:
2017-07-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-02
Last Update Post Date:
2022-08-03
Last Update Post Date Type:
ACTUAL